PBS tightens up on FDC inhaler use in child asthma

The PBS restriction level for fixed dose combination inhaled corticosteroid (ICS)/long acting beta-antagonist (LABA) inhalers for childhood asthma is to be increased to Authority Required (Streamlined), the Pharmaceutical Benefits Advisory Committee (PBAC) has signalled . The move is a reiteration of the PBAC’s 2017 recommendations aimed at curbing inappropriate first line use of fixed dose combination ...

Already a member?

Login to keep reading.

© 2021 the limbic